CEC // Clinical Trials Centre

2020
  • Characterization of disease progression in the initial stages of retinopathy in diabetes type 2. A two-year longitudinal study.

    Inês P. Marques, Dalila Alves, Torcato Santos, Luís Mendes, Conceição Lobo, Ana Rita Santos, Mary Durbin, José Cunha-Vaz

    Invest Ophthalmol Vis Sci. 2020 Mar 9;61(3):20. doi: 10.1167/iovs.61.3.20.

    2020

    + info
  • Retinopathy Phenotypes in Type 2 Diabetes with Different Risks for Macular Edema and Proliferative Retinopathy.

    Marques IP, Madeira MH, Messias AL, Santos T, Martinho A. C-V. Figueira J, Cunha-Vaz J.

    J. Clin. Med. 2020, 9(5), 1433; https://doi.org/10.3390/jcm9051433

    2020

    + info
  • Microperimetry and MFERG as Functional Measurements in Diabetic Macular Edema Undergoing Intravitreal Ranibizumab Treatment.

    Ana Rita Santos, Miguel Raimundo, Dalila Alves, Marta Lopes, Sérgio Pestana, João Figueira, José Cunha-Vaz & Rufino Silva

    Eye (2020) https://doi.org/10.1038/s41433-020-1054-2

    2020

     

    + info
  • The Usefulness of Serum Biomarkers in the Early Stages of Diabetic Retinopathy: Results of the EUROCONDOR Clinical Trial.

    Cristina Hernández , Massimo Porta , Francesco Bandello , Jakob Grauslund ,Simon P. Harding , Stephen J. Aldington, Catherine Egan, Ulrik Frydkjaer-Olsen,José García-Arumí, Jonathan Gibson, Gabriele E. Lang, Rosangela Lattanzio ,Pascale Massin, Edoardo Midena, Berta Ponsati, Luísa Ribeiro, Peter Scanlon, José Cunha-Vaz and Rafael Simó for the European Consortium for the Early Treatment of Diabetic retinopathy.

    J. Clin. Med. 2020, 9, 1233; doi:10.3390/jcm9041233

    2020

    + info